Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection: A case report

Jairo Arturo Noreña; César Daniel Niño; Sabrina Gallego; Carlos Alfonso Builes-Barrera; Diva Cristina Castro; Alejandro Román-González; Camilo Jimenez

doi:10.11138/ccmbm/2017.14.3.340

Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection: A case report

Jairo Arturo Noreña, César Daniel Niño, Sabrina Gallego, Carlos Alfonso Builes-Barrera, Diva Cristina Castro, Alejandro Román-González, Camilo Jimenez

Endocrine Neoplasia & HD

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Soft-tissue filler (STF) injections have been used worldwide for cosmetic reasons. In most cases, they are not approved by the United States Food and Drug Administration (FDA). Regulatory boards in Latin American countries do not allow the medical use of STF injections; however, these injections are still widely used. A case of calcitriol-mediated hypercalcemia with ectopic calcifications, chronic kidney disease, nephrolithiasis and calcinosis is presented. The reported case highlights the consequences of STF use, including calcitriol-mediated hypercalcemia secondary to granulomatous reactions years after an esthetic procedure.

Original language	English (US)
Pages (from-to)	340-346
Number of pages	7
Journal	Clinical Cases in Mineral and Bone Metabolism
Volume	14
Issue number	3
DOIs	https://doi.org/10.11138/ccmbm/2017.14.3.340
State	Published - Oct 1 2017

Keywords

Calcinosis
Calcitriol
Granulomatous disorders
Hypercalcemia
Soft-tissue filler

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.11138/ccmbm/2017.14.3.340

Cite this

@article{dcddb8a2a81044c7894d942eb5b7b86e,

title = "Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection: A case report",

abstract = "Soft-tissue filler (STF) injections have been used worldwide for cosmetic reasons. In most cases, they are not approved by the United States Food and Drug Administration (FDA). Regulatory boards in Latin American countries do not allow the medical use of STF injections; however, these injections are still widely used. A case of calcitriol-mediated hypercalcemia with ectopic calcifications, chronic kidney disease, nephrolithiasis and calcinosis is presented. The reported case highlights the consequences of STF use, including calcitriol-mediated hypercalcemia secondary to granulomatous reactions years after an esthetic procedure.",

keywords = "Calcinosis, Calcitriol, Granulomatous disorders, Hypercalcemia, Soft-tissue filler",

author = "Nore{\~n}a, {Jairo Arturo} and Ni{\~n}o, {C{\'e}sar Daniel} and Sabrina Gallego and Builes-Barrera, {Carlos Alfonso} and Castro, {Diva Cristina} and Alejandro Rom{\'a}n-Gonz{\'a}lez and Camilo Jimenez",

year = "2017",

month = oct,

day = "1",

doi = "10.11138/ccmbm/2017.14.3.340",

language = "English (US)",

volume = "14",

pages = "340--346",

journal = "Clinical Cases in Mineral and Bone Metabolism",

issn = "1724-8914",

publisher = "CIC Edizioni Internazionali s.r.l.",

number = "3",

}

TY - JOUR

T1 - Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection

T2 - A case report

AU - Noreña, Jairo Arturo

AU - Niño, César Daniel

AU - Gallego, Sabrina

AU - Builes-Barrera, Carlos Alfonso

AU - Castro, Diva Cristina

AU - Román-González, Alejandro

AU - Jimenez, Camilo

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Soft-tissue filler (STF) injections have been used worldwide for cosmetic reasons. In most cases, they are not approved by the United States Food and Drug Administration (FDA). Regulatory boards in Latin American countries do not allow the medical use of STF injections; however, these injections are still widely used. A case of calcitriol-mediated hypercalcemia with ectopic calcifications, chronic kidney disease, nephrolithiasis and calcinosis is presented. The reported case highlights the consequences of STF use, including calcitriol-mediated hypercalcemia secondary to granulomatous reactions years after an esthetic procedure.

AB - Soft-tissue filler (STF) injections have been used worldwide for cosmetic reasons. In most cases, they are not approved by the United States Food and Drug Administration (FDA). Regulatory boards in Latin American countries do not allow the medical use of STF injections; however, these injections are still widely used. A case of calcitriol-mediated hypercalcemia with ectopic calcifications, chronic kidney disease, nephrolithiasis and calcinosis is presented. The reported case highlights the consequences of STF use, including calcitriol-mediated hypercalcemia secondary to granulomatous reactions years after an esthetic procedure.

KW - Calcinosis

KW - Calcitriol

KW - Granulomatous disorders

KW - Hypercalcemia

KW - Soft-tissue filler

UR - http://www.scopus.com/inward/record.url?scp=85041660382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041660382&partnerID=8YFLogxK

U2 - 10.11138/ccmbm/2017.14.3.340

DO - 10.11138/ccmbm/2017.14.3.340

M3 - Article

C2 - 29354165

AN - SCOPUS:85041660382

SN - 1724-8914

VL - 14

SP - 340

EP - 346

JO - Clinical Cases in Mineral and Bone Metabolism

JF - Clinical Cases in Mineral and Bone Metabolism

IS - 3

ER -

Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection: A case report

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this